For example, several groups have investigated the use of next-generation pro-cytokines that are activated specifically within the TME, as recently demonstrated by Guo et al. using a tumor-conditional IL-15 pro-cytokine to enhance memory development and antitumor efficacy while minimizing systemic toxicity [164]. This evidence concerns the gene IL15 and neoplasm.